Viridian Therapeutics Inc. – Material Contracts Watch

from 10-K 37 pages Purchase and Sale Agreement by and Between Viridian Therapeutics, Inc. and Dri Healthcare Acquisitions LP Dated as of October 17, 2025

from 10-Q 13 pages Sixth Amendment to Lease

from 10-Q 74 pages Collaboration and License Agreement by and Between Viridian Therapeutics, Inc. and Kissei Pharmaceutical Co., Ltd. Dated as of July 30, 2025

from 10-Q 12 pages Viridian Therapeutics, Inc. 2025 Employee Stock Purchase Plan Adopted by the Board of Directors: April 23, 2025 Approved by the Stockholders: June 20, 2025

from 8-K 22 pages Viridian Therapeutics, Inc. Amended & Restated 2016 Equity Incentive Plan Adopted by the Board of Directors: April 23, 2025 Approved by the Stockholders: June 20, 2025

from 10-Q 11 pages Viridian Therapeutics, Inc. Employment Agreement

from 10-Q 18 pages March 1, 2025 by Email 1. Employment Status; Final Payments; Benefits Cessation: 2. Consideration. in Exchange for and in Consideration of Your Executing and Complying With This Agreement and Any Other Agreements Between You and the Company, and Pursuant to Your Employment Agreement With the Company Dated January 12, 2023

from 10-K 4 pages Viridian Therapeutics, Inc. Amendment to Employment Agreement

from 10-K 4 pages Viridian Therapeutics, Inc. Amendment to Employment Agreement

from 10-K 4 pages Viridian Therapeutics, Inc. Amendment to Employment Agreement

from 10-K 4 pages Viridian Therapeutics, Inc. Amendment to Employment Agreement

from 10-Q 42 pages [***] = Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Information That the Company Customarily and Actually Treats as Private or Confidential and (II) Is Not Material. Amended and Restated License Agreement

from 10-Q 12 pages Fifth Amendment to Lease

from 10-Q 11 pages Fourth Amendment to Lease

from 8-K 22 pages Viridian Therapeutics, Inc. Amended & Restated 2016 Equity Incentive Plan Adopted by the Board of Directors: April 19, 2024 Approved by the Stockholders: June 17, 2024

from 10-K 11 pages Viridian Therapeutics, Inc. 2016 Amended and Restated Employee Stock Purchase Plan Adopted by the Board of Directors: November 30, 2016 Approved by the Stockholders: February 10, 2017 Amended and Restated by the Board of Directors: March 30, 2023

from 10-K 6 pages Viridian Therapeutics, Inc. (The “Company”), Pursuant to Its 2016 Amended and Restated Equity Incentive Plan (The “Plan”), Hereby Awards to Participant the Number of Restricted Stock Units Set Forth Below (“Award”). This Award Is Subject to All of the Terms and Conditions as Set Forth Herein and in the Restricted Stock Unit Agreement and the Plan, All of Which Are Attached Hereto and Incorporated Herein in Their Entirety. Capitalized Terms Not Otherwise Defined Herein Shall Have the Meanings Set Forth in the Plan or the Restricted Stock Unit Agreement. in the Event of Any Conflict Between the Terms in the Award and the Plan, the Terms of the Plan Shall Control. Participant: Date of Grant: Vesting Commencement Date: Number of Restricted Stock Units: Consideration: Participant’s Services Vesting Schedule

from 10-K 8 pages Viridian Therapeutics, Inc. Amended and Restated 2016 Equity Incentive Plan Stock Option Grant Notice

from 10-K 11 pages Viridian Therapeutics, Inc. Employment Agreement

from 10-K 2 pages Amendment to Employment Agreement